months after adrenalectomy, she remains well, and there is no sign of remaining pituitary tumor growth on magnetic resonance imaging (Fig. 1a) .
In patients with Cushing's disease who are refractory to initial treatments for pituitary tumor, hypercortisolemia must be managed medically or surgically [1] . Although bilateral adrenalectomy is the most reliable option for the treatment of hypercortisolemia, it may be associated with potential risk of pituitary tumor growth, known as Nelson's syndrome [2] . Therefore, physicians are often reluctant to decide adrenalectomy [3] . On the other hand, the "escape" phenomenon from response has been reported in the longterm treatment with steroidogenesis inhibitors [1] . Although the underlying mechanism of the phenomenon remains unclear, as for metyrapone, long-term treatment may result in "escape" in 4-13% of patients (Table 1 ) [4] [5] [6] . A plausible explanation of "escape" in the current case would be that long-term stimulation by ACTH lead to marked enlargement of adrenal glands with robust production of cortisol, which could not be suppressed by high-dose metyrapone. Another possibility is that enlarged adrenal glands autonomously secreted cortisol, as suggested by previous reports [1, 7, 8] . However, because of persistently elevated plasma ACTH in the current case, it is difficult to determine whether cortisol was autonomously produced independently of ACTH.
In conclusion, the current case highlights the difficulty in long-term treatment of Cushing's disease, especially with metyrapone. The optimal timing for bilateral adrenalectomy is not clearly defined, and physicians must make difficult decisions in the management of refractory Cushing's disease. 
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